Analyst Ratings for Quest Diagnostics

01:10pm, Friday, 22'nd Apr 2022 Benzinga
Quest Diagnostics (NYSE:DGX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 5 0 0 Last 3
The Justice Department has filed an appeal seeking to overturn a federal judge's ruling that ended the face-mask mandate on planes and other modes of public transportation, after the Centers for Disea
Quest Diagnostics Incorporated (NYSE:DGX ) Q1 2022 Earnings Conference Call April 21, 2022 8:30 AM ET Company Participants Shawn Bevec - Vice President, Investor Relations Steve Rusckowski - Chairman

Quest Diagnostics (DGX) Beats Q1 Earnings Estimates

12:15pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 10.65% and 1.02%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 10.65% and 1.02%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Should You Buy Quest Diagnostics (DGX) Ahead of Earnings?

12:42pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
Quest Diagnostics (DGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Quest Diagnostics (DGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Quest Diagnostics (DGX) Q1 Earnings to Grow on Base Business

01:03pm, Monday, 18'th Apr 2022 Zacks Investment Research
Quest Diagnostics (DGX) is expected to report a strong first half of Q1 with a growing number of cases and then a dull second half on gradual stabilization in testing demand.
Quest Diagnostics (DGX) is expected to report a strong first half of Q1 with a growing number of cases and then a dull second half on gradual stabilization in testing demand.
Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quest Diagnostics' (DGX) new collaboration with IRIS will enhance access to diabetic retinopathy screening in the United States.

Analyst Ratings For Quest Diagnostics

03:04pm, Monday, 04'th Apr 2022 Benzinga
Quest Diagnostics (NYSE:DGX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 0 6 0 0 Last 3
Upgrades According to Scotiabank, the prior rating for Welltower Inc (NYSE:WELL) was changed from Sector Perform to Sector Outperform. In the fourth quarter, Welltower showed an EPS of $0.83, compared

A Wake-Up Call for Bargain Hunters

10:32am, Monday, 04'th Apr 2022
For bargain hunters, every stock market cloud has a silver lining. After a rough first quarter, dozens of stocks have descended to what I consider attractive levels.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE